Boylan M O, Athanassiou M, Houle B, Wang Y, Zarbl H
Division of Toxicology, Massachusetts Institute of Technology, Cambridge 02139, USA.
Cell Growth Differ. 1996 Jun;7(6):725-35.
Two nontransformed revertants of HeLa cells, designated HA and HF, were isolated using a selection procedure based on prolonged retention of the fluorescent dye rhodamine 123 within the mitochondria of HeLa (ATCC CCL2) cells versus normal epithelial cells. Unlike the parental HeLa cells, the revertants expressed markedly reduced levels of the bone-liver-kidney, placental, and intestinal isoforms of alkaline phosphatase, exhibited a flat nonrefractile morphology, and failed to grow in suspension culture. The revertant clones had > 100-fold reduced cloning efficiencies in semisolid medium relative to HeLa cells and failed to induce s.c. tumors when injected into nude mice. Both revertant clones have retained nontransformed phenotypes after 5 years of continuous culture. Southern blot analyses performed with human papillomavirus 18-specific DNA probes indicated that the integrated viral sequences present in HeLa cells remained intact in the revertants. Furthermore, the level of the polycistronic mRNAs encoding the viral E6 and E7 oncogenes were comparable in the parental HeLa cell line and the revertants. Western blot analyses of immunoprecipitated human papillomavirus 18 E6 and E7 proteins further demonstrated that the levels of these viral oncoproteins were comparable in HeLa cells and revertants. Infection with helper-free, defective retroviruses that express E6, E7 or E6 and E7 oncogenes failed to retransform the revertants, suggesting that their nontransformed phenotype did not result from mutations in these viral oncogenes. Cell fusion experiments indicated that the revertant phenotypes of HA and HF cells resulted from mutations in cellular genes that activate one or more tumor suppressor genes.
通过一种基于若丹明123荧光染料在HeLa(ATCC CCL2)细胞线粒体中相对于正常上皮细胞的长时间保留的筛选程序,分离出了两个非转化的HeLa细胞回复突变体,分别命名为HA和HF。与亲代HeLa细胞不同,回复突变体中碱性磷酸酶的骨-肝-肾、胎盘和肠同工型的表达水平显著降低,呈现扁平无折射的形态,并且无法在悬浮培养中生长。回复突变体克隆在半固体培养基中的克隆效率相对于HeLa细胞降低了100倍以上,并且注射到裸鼠体内时不能诱导皮下肿瘤。经过5年的连续培养,两个回复突变体克隆都保留了非转化表型。用人乳头瘤病毒18特异性DNA探针进行的Southern印迹分析表明,HeLa细胞中存在的整合病毒序列在回复突变体中保持完整。此外,编码病毒E6和E7癌基因的多顺反子mRNA水平在亲代HeLa细胞系和回复突变体中相当。对免疫沉淀的人乳头瘤病毒18 E6和E7蛋白进行的Western印迹分析进一步证明,这些病毒癌蛋白的水平在HeLa细胞和回复突变体中相当。用表达E6、E7或E6和E7癌基因的无辅助缺陷逆转录病毒感染未能使回复突变体重转化,这表明它们的非转化表型不是由这些病毒癌基因的突变引起的。细胞融合实验表明,HA和HF细胞的回复突变体表型是由激活一个或多个肿瘤抑制基因的细胞基因突变导致的。